304 related articles for article (PubMed ID: 17412850)
1. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
[TBL] [Abstract][Full Text] [Related]
2. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
[TBL] [Abstract][Full Text] [Related]
3. Long-term combination antipsychotic treatment in VA patients with schizophrenia.
Kreyenbuhl J; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
Schizophr Res; 2006 May; 84(1):90-9. PubMed ID: 16631354
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Shi L; Ascher-Svanum H; Zhu B; Faries D; Montgomery W; Marder SR
Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
[TBL] [Abstract][Full Text] [Related]
6. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
7. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
Mohamed S; Leslie DL; Rosenheck RA
J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
[TBL] [Abstract][Full Text] [Related]
8. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC
Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540
[TBL] [Abstract][Full Text] [Related]
9. Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.
Kadra G; Stewart R; Shetty H; Downs J; MacCabe JH; Taylor D; Hayes RD
Schizophr Res; 2016 Jul; 174(1-3):106-112. PubMed ID: 27091655
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.
Clark RE; Bartels SJ; Mellman TA; Peacock WJ
Schizophr Bull; 2002; 28(1):75-84. PubMed ID: 12047024
[TBL] [Abstract][Full Text] [Related]
11. The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.
Van Dorn RA; Swanson JW; Swartz MS; Elbogen EB
Ment Health Serv Res; 2005 Jun; 7(2):123-34. PubMed ID: 15974158
[TBL] [Abstract][Full Text] [Related]
12. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors.
Leslie DL; Rosenheck RA
Med Care; 2001 Sep; 39(9):923-33. PubMed ID: 11502950
[TBL] [Abstract][Full Text] [Related]
13. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
14. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
Valenstein M; Copeland LA; Owen R; Blow FC; Visnic S
J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
[TBL] [Abstract][Full Text] [Related]
15. Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.
Kikkert MJ; de Mooij L; de Koning M; Dekker J
J Clin Psychiatry; 2021 Dec; 83(1):. PubMed ID: 34936243
[No Abstract] [Full Text] [Related]
16. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.
Park SC; Lee MS; Kang SG; Lee SH
J Korean Med Sci; 2014 May; 29(5):719-28. PubMed ID: 24851031
[TBL] [Abstract][Full Text] [Related]
17. Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.
Ren XS; Kazis LE; Lee AF; Huang YH; Hamed A; Cunningham F; Herz L; Miller DR
Schizophr Res; 2005 Sep; 77(2-3):167-77. PubMed ID: 15894460
[TBL] [Abstract][Full Text] [Related]
18. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
[TBL] [Abstract][Full Text] [Related]
19. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
Levinson DF; Umapathy C; Musthaq M
Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
[TBL] [Abstract][Full Text] [Related]
20. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.
Glick ID; Pham D; Davis JM
J Clin Psychiatry; 2006 Aug; 67(8):1261-5. PubMed ID: 16965205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
